Jounce Therapeutics Inc. (JNCE) Climbed 5.91% or 0.33 To Price $5.91 On Friday


Jounce Therapeutics Inc. (JNCE) climbed 5.91% or 0.33 to $5.91. It is near to 71751 shares traded, which is 47.82% compare to the average total volume 150052. The market cap of JNCE is $194.87 million. The year to date change is 50.1%. The 52 week price range is from $2.66 to $18.45. Price of JNCE have changed -3.63% during last week. It have changed -11.85% over last month, 31.29% over last 3 months, 25.11% over last 6 months and -63.88% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for JNCE is 5.92. It is 0.17% above current price. The stock faces resistance at 50-day moving averages. The 200-day Moving Averages for JNCE is 5.57. It is -5.75% below current price. The 52-week High is 18.45. It is 212.18% from the current price. The 52-week Low is 2.66. It is -54.99% from current price.

There are some statistics of JNCE. It is has market cap $194.87 million. The share outstanding is 32.97 million. The average volume is 150052. The percent of top 15 Institution holding is 83.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of JNCE is -20.73%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of JNCE is -10.99%.


Tags:

Share this post